Unresectable intrahepatic cholangiocarcinoma: TARE or TACE, which one to choose?

Unresectable intrahepatic cholangiocarcinoma: TARE or TACE, which one to choose?

Intrahepatic cholangiocarcinoma (ICC) is the second most common primary liver malignancy and its incidence is rising in Western countries. Although surgical resection is considered the only curative treatment, up to 70% of patients are diagnosed at an advanced stage, which precludes surgical interve...

Full description

Bibliographic Details
Main Authors: Maria Adriana Cocozza, Lorenzo Braccischi, Antonio De Cinque, Antonio Bruno, Alberta Cappelli, Matteo Renzulli, Antonello Basile, Massimo Venturini, Pierleone Lucatelli, Francesco Modestino, Cristina Mosconi
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-10-01
Series:Frontiers in Gastroenterology
Subjects:
intrahepatic cholangiocarcinoma
TACE
TARE
radioembolization
intrarterial therapies
Online Access:https://www.frontiersin.org/articles/10.3389/fgstr.2023.1270264/full

Internet

https://www.frontiersin.org/articles/10.3389/fgstr.2023.1270264/full

Similar Items